The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Philippines seals biggest COVID-19 vaccine order yet, for 40 mln Pfizer doses

Sun, 20th Jun 2021 16:45

* Deliveries to begin in late September

* Philippines has secured 113 mln doses from vaccine
suppliers

* Government wants to vaccinate up to 70 million Filipinos
(Updates with Israel medical experts arriving to help boost
vaccine rollout)

MANILA, June 20 (Reuters) - The Philippine government has
signed a supply agreement for 40 million doses of the COVID-19
vaccine developed by Pfizer Inc and BioNTech SE,
in its biggest coronavirus vaccine deal to date.

Deliveries of the vaccine will begin in late September,
Carlito Galvez, head of the government's COVID-19 vaccine
procurement, said on Sunday. It "will significantly boost our
national immunisation programme and will enable us to realise
our goal of achieving herd immunity by year-end," he said.

The Philippines has now ordered 113 million doses from five
vaccine manufacturers, including 26 million from China's Sinovac
, 10 million of Russia's Sputnik V, 20 million doses from
Moderna and 17 million doses from AstraZeneca.

So far, the Philippines has adminstered slightly more than 8
million doses, of which about 6 million were first doses, making
slow progress towards the government's target to vaccinate up to
70 million people this year in a country of 110 million.

The Philippines earlier this month started a programme to
vaccinate 35 million people working outside their homes, while
continuing to inoculate priority sectors such as healthcare
workers and the elderly.

Vaccine supply around the capital Manila remains limited,
while COVID-19 cases in several provinces have surged,
complicating efforts to ramp up the immunisation drive in a
country with some of Asia's largest numbers of infections and
deaths.

The Philippines also expects 44 million doses from the
international COVAX vaccine sharing facility. Orders of 16
million doses of vaccines developed by Novavax and
Johnson & Johnson were still under negotiation, Galvez
said.

The Philippines will allow the Pfizer-BioNTech vaccine to be
given to children aged 12 to 15, possibly starting later this
year, he said.

To help boost the government's COVID-19 response, a team of
medical experts from the Israel Ministry of Health has arrived
in Manila. Israel has been a world leader in rolling out
vaccines, having successfully reduced its active COVID-19 cases
and gradually reopened its economy. Most of its population has
received the Pfizer-BioNTech vaccine.

Galvez said the health experts will share strategies,
including how to address vaccine hesitancy.
(Reporting by Enrico Dela Cruz; Editing by William Mallard and
Christopher Cushing)

More News
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.